RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5355
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1427100; Gene model (P.falciparum): PF3D7_0810400; Gene product: aquaporin, putative (aquaporin 2, AQP2)
Name tag: triple-HA
Transgene
Transgene not Plasmodium: GFP (gfp-mu3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Gametocyte/Gamete; Fertilization and ookinete; Sporozoite;
Last modified: 29 October 2023, 17:30
  *RMgm-5355
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 37883438
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherBaily AJ, Vlachou D
Name Group/DepartmentDepartment of Life Sciences
Name InstituteImperial College London
CityLondon
CountryUK
Name of the mutant parasite
RMgm numberRMgm-5355
Principal nameaqp2::3xha
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteWestern blot analysis of aqp2::3xha parasite protein extracts using an antibody against the HA epitope showed the expected ca. 73 kDa protein predominantly in gametocytes – already prior to gametogenesis activation and, at a lower abundance, in mature ookinetes.
In indirect immunofluorescence assays of aqp2::3xha parasites, AQP2::3xHA was seen to specifically localize to vesicle-like structures in the cytoplasm of gametocytes, ookinetes and midgut sporozoites. The number and appearance of these structures varied from 1-2 large spots and several smaller ones in gametocytes, 2-3 and occasionally 1-4 spots in ookinetes, and 2-3 spots in sporozoites.
Fertilization and ookineteWestern blot analysis of aqp2::3xha parasite protein extracts using an antibody against the HA epitope showed the expected ca. 73 kDa protein predominantly in gametocytes – already prior to gametogenesis activation and, at a lower abundance, in mature ookinetes.
In indirect immunofluorescence assays of aqp2::3xha parasites, AQP2::3xHA was seen to specifically localize to vesicle-like structures in the cytoplasm of gametocytes, ookinetes and midgut sporozoites. The number and appearance of these structures varied from 1-2 large spots and several smaller ones in gametocytes, 2-3 and occasionally 1-4 spots in ookinetes, and 2-3 spots in sporozoites. In ookinetes, this pattern resembles that of crystalloid, an elusive organelle exclusive to ookinetes and young oocysts. Although these spots were often seen adjacent to the hemozoin crystals, the waste product of hemoglobin metabolism and hallmark of the ABS food vacuole and the crystalloid, they never fully colocalized with the hemozoin or located amongst the hemozoin crystals where the crystalloid is found. Indeed, the diameter of these structures in ookinetes (0.2-0.7 μm) was smaller than that of crystalloids (0.3-1.15 μm) as determined by IFAs of the recently identified crystalloid proteins CRYSP and CRONE. The diameter of these structures was more uniform in all sporozoites examined (0.25-0.4 μm).
OocystNot tested
SporozoiteIn indirect immunofluorescence assays of aqp2::3xha parasites, AQP2::3xHA was seen to specifically localize to vesicle-like structures in the cytoplasm of gametocytes, ookinetes and midgut sporozoites. The number and appearance of these structures varied from 1-2 large spots and several smaller ones in gametocytes, 2-3 and occasionally 1-4 spots in ookinetes, and 2-3 spots in sporozoites. In ookinetes, this pattern resembles that of crystalloid, an elusive organelle exclusive to ookinetes and young oocysts. Although these spots were often seen adjacent to the hemozoin crystals, the waste product of hemoglobin metabolism and hallmark of the ABS food vacuole and the crystalloid, they never fully colocalized with the hemozoin or located amongst the hemozoin crystals where the crystalloid is found. Indeed, the diameter of these structures in ookinetes (0.2-0.7 μm) was smaller than that of crystalloids (0.3-1.15 μm) as determined by IFAs of the recently identified crystalloid proteins CRYSP and CRONE. The diameter of these structures was more uniform in all sporozoites examined (0.25-0.4 μm).
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant  expresses a C-terminal 3xHA-tagged version of AQP2 and expresses GFP under control of the constitutive eef1a promoter.

Protein (function)
Plasmodium AQP1 is a well-characterized plasma membrane aquaglyceroporin that conducts water, glycerol, and ammonia at high rates. It is expressed throughout parasite asexual blood stages (ABS), sporozoites and infected hepatocytes, and provides parasites access to serum glycerol for membrane lipid synthesis. Whilst the essentiality of AQP1 to ABS is disputed, it is established that the protein is important for progression of hepatic stage infection. A second putative aquaporin, AQP2, has been identified in Plasmodium genomes and reported to be phylogenetically associated more closely to T. gondii AQP1, rather than Plasmodium AQP1. 

From the paper: 
'Phylogenetic analysis along Alphafold structure predictions revealed that AQP2 is distinct from AQP1, other aquaglyceroporins and orthodox aquaporins with regards to both its overall architecture and pore selectivity filter. AQP2 orthologs are found in all plasmodia with available genome sequences. They encode large aquaporin-like proteins of 603 amino acids in P. falciparum (PfAQP2, PF3D7_0810400) and 595 amino acids in P. berghei (PbAQP2, PBANKA_1427100). Multiple sequence alignment identified regions of high conservation mostly associated with predicted a-helixes. One region is substantially divergent between species, both in terms of sequence identity and length: amino acids 110-228 in PfAQP2 and 110-215 in PbAQP2. Insertions in this region cause AQP2s of human parasites of the sub-genus Plasmodium (P. malariae, P. vivax and P. knowlesi) to be considerably longer than other AQP2s. Protein structure predictions made with Alphafold Monomer v2.0 showed that PfAQP2 and PbAQP2, like all aquaporins, have six full transmembrane helices and two half helices, connected by five loops. The variable region corresponds to extracellular loop A that lies between helixes 1 and 2. Loop A is highly charged, with roughly 40% of amino acids carrying either a positive or negative charge. Intracellular loop D is longer than extracellular loop C, the inverse of loop lengths of Plasmodium AQP1. The characteristic aquaporin pore forming NPA motifs are present in all AQP2s, in half-helices 1 and 2 that are part of loops B and E, respectively. While the first NPA motif is present as a canonical NPA. Finally, in all AQP2s, the canonical arginine residue that determines the selectivity filter, invariably found directly adjacent to the second NPA motif, is replaced with phenylalanine (R>F).'

Phenotype
Analysis of a mutant lacking expression of AQP2 (RMgm-5354) showed the following: 
'Normal asexual blood stage development, gametocyte, ookinete and oocyst production. However, sporozoite formation inside oocysts is severely affected. Both Δpbaqp2 oocyst and salivary gland sporozoites were severely reduced.
DAPI staining of Δpbaqp2 oocysts at day 15 after feeding revealed that nuclei were large and disorganized unlike wild type oocysts that had highly organized nuclei, characteristic of sporozoites that had budded off from the central sporoblastoid body.
Almost total absence of Δpbaqp2 sporozoites in the mosquito salivary glands. No transmission to mice by mosquito bite'.

Western blot analysis of aqp2::3xha parasite protein extracts using an antibody against the HA epitope showed the expected ca. 73 kDa protein predominantly in gametocytes – already prior to gametogenesis activation and, at a lower abundance, in mature ookinetes.
In indirect immunofluorescence assays of aqp2::3xha parasites, AQP2::3xHA was seen to specifically localize to vesicle-like structures in the cytoplasm of gametocytes, ookinetes and midgut sporozoites. The number and appearance of these structures varied from 1-2 large spots and several smaller ones in gametocytes, 2-3 and occasionally 1-4 spots in ookinetes, and 2-3 spots in sporozoites. In ookinetes, this pattern resembles that of crystalloid, an elusive organelle exclusive to ookinetes and  young oocysts. Although these spots were often seen adjacent to the hemozoin crystals, the waste product of hemoglobin metabolism and hallmark of the ABS food vacuole and the crystalloid, they never fully colocalized with the hemozoin or located amongst the hemozoin crystals where the crystalloid is found. Indeed, the diameter of these structures in ookinetes (0.2-0.7 μm) was smaller than that of crystalloids (0.3-1.15 μm) as determined by IFAs of the recently identified crystalloid proteins CRYSP and CRONE. The diameter of these structures was more uniform in all sporozoites examined (0.25-0.4 μm).

Additional information

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1427100
Gene Model P. falciparum ortholog PF3D7_0810400
Gene productaquaporin, putative
Gene product: Alternative nameaquaporin 2, AQP2
Details of the genetic modification
Name of the tagtriple-HA
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) PCR construct double cross-over
PlasmoGEM (Sanger) construct/vector usedYes
Name of PlasmoGEM construct/vector-
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationGeneration of P. berghei Δpbaqp2 and pbaqp2::3xha:
We used the PlasmoGEM vectors PbGEM_321755 and PbGEM-066039 for PbAQP2 disruption and C-terminal 3xHA tagging, respectively. These vectors contain the human DHFR (hDHFR) selection cassette that confers resistance to pyrimethamine and the negative selection cassette yFCU that substitutes the delivery of 5-fluorocytosine. The targeting cassettes were released by NotI digestion resulting in 74% deletion of PbAQP2 coding sequence at the gene 5′ end.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mu3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modificationThe GFP gene (1 copy) has been inserted into the 230p locus (PBANKA_030600) by double cross-over integration.
Additional remarks selection procedureThis reporter mutant expressing GFP does not contain a drug-selectable marker. This mutant has been selected by FACS sorting after transfection based on GFP fluorescence
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4